Discontinuation of Coverage: Xifaxan (Rifaximin)*
Effective October 1, 2025, the manufacturer of Xifaxan (Rifaximin) will no longer participate in the Medicaid Drug Rebate Program which means it will not be covered by MaineCare. Please read below for alternative options.
Patient Assistance Program for Free Medication
Bausch Health Companies, Inc. offers a patient assistance program aimed at supplying free medication, including Xifaxan, to eligible patients who do not have coverage under their Medicaid pharmacy benefit.